SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
TECX
276
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
|
MF
Mani Foroohar
| $17.22 | $120 |
597%
upside
| Market Perform |
3 May ‘21
4 years ago |
|
277
Align Technology
ALGN
$9.85B
|
RN
Richard Newitter
| $135.93 | $770 |
466%
upside
| Outperform |
29 Apr ‘21
4 years ago |
|
278
Hologic
HOLX
$14.8B
|
RN
Richard Newitter
| $66.72 | $85 |
27%
upside
| Outperform |
29 Apr ‘21
4 years ago |
|
279
Senseonics Holdings
SENS
$362M
|
DA
Danielle Antalffy
| $0.4440 | $3 |
576%
upside
| Market Perform |
1 Apr ‘21
4 years ago |
|
280
Galecto
GLTO
$3.42M
|
TS
Thomas Smith
| $2.58 | $400 |
15,404%
upside
| Outperform |
16 Mar ‘21
4 years ago |
|
281
Aclaris Therapeutics
ACRS
$231M
|
TS
Thomas Smith
| $2.13 | $26 |
1,121%
upside
| Outperform |
4 Mar ‘21
4 years ago |
|
282
LENSAR
LNSR
$147M
|
RN
Richard Newitter
| $12.20 | $20 |
64%
upside
| Outperform |
24 Feb ‘21
4 years ago |
|
283
Jazz Pharmaceuticals
JAZZ
$7.88B
|
AF
Ami Fadia
| $128.53 | $210 |
63%
upside
| Outperform |
24 Feb ‘21
4 years ago |
|
284
Axogen
AXGN
$738M
|
RN
Richard Newitter
| $16.42 | $27 |
64%
upside
| Outperform |
23 Feb ‘21
4 years ago |
|
|
AMRN
285
Amarin Corp
AMRN
$306M
|
AF
Ami Fadia
| $15.22 | $320 |
2,003%
upside
| Outperform |
1 Feb ‘21
4 years ago |
|
286
Johnson & Johnson
JNJ
$429B
|
DA
Danielle Antalffy
| $176.96 | $200 |
13%
upside
| Outperform |
27 Jan ‘21
4 years ago |
|
287
Pacira BioSciences
PCRX
$1.2B
|
AF
Ami Fadia
| $26.30 | $75 |
185%
upside
| Market Perform |
21 Jan ‘21
4 years ago |
|
288
Tempest Therapeutics
TPST
$48.2M
| $11 | $30 |
173%
upside
| Market Perform |
6 Jan ‘21
4 years ago |
|
|
289
UnitedHealth
UNH
$315B
|
ST
Stephen Tanal
| $347.92 | $390 |
12%
upside
| Outperform |
14 Dec ‘20
4 years ago |
|
290
eHealth
EHTH
$119M
|
ST
Stephen Tanal
| $3.90 | $105 |
2,592%
upside
| Outperform |
14 Dec ‘20
4 years ago |
|
291
CVS Health
CVS
$91B
|
ST
Stephen Tanal
| $71.75 | $80 |
12%
upside
| Market Perform |
14 Dec ‘20
4 years ago |
|
292
Centene
CNC
$15.3B
|
ST
Stephen Tanal
| $31.06 | $75 |
141%
upside
| Outperform |
14 Dec ‘20
4 years ago |
|
293
Cigna
CI
$80.3B
|
ST
Stephen Tanal
| $302.01 | $240 |
21%
downside
| Market Perform |
14 Dec ‘20
4 years ago |
|
294
Elevance Health
ELV
$69.4B
|
ST
Stephen Tanal
| $315.09 | $400 |
27%
upside
| Outperform |
14 Dec ‘20
4 years ago |
|
295
Ardelyx
ARDX
$1.59B
| $6.56 | $14 |
113%
upside
| Outperform |
11 Dec ‘20
4 years ago |
|
|
296
Keros Therapeutics
KROS
$628M
|
TS
Thomas Smith
| $15.71 | $80 |
409%
upside
| Outperform |
8 Dec ‘20
4 years ago |
|
297
Heron Therapeutics
HRTX
$199M
| $1.30 | $24 |
1,746%
upside
| Outperform |
2 Dec ‘20
4 years ago |
|
|
298
AdaptHealth
AHCO
$1.27B
|
ST
Stephen Tanal
| $9.23 | $39.50 |
328%
upside
| Outperform |
2 Dec ‘20
4 years ago |
|
299
Humana
HUM
$32.8B
|
ST
Stephen Tanal
| $273.02 | $500 |
83%
upside
| Outperform |
30 Nov ‘20
4 years ago |
|
300
Amneal Pharmaceuticals
AMRX
$3.06B
| $9.89 | $5.50 |
44%
downside
| Market Perform |
9 Nov ‘20
4 years ago |
|